These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Double-blind evaluation of naftidrofuryl in treating elderly confused hospitalised patients. Cox JR Gerontol Clin (Basel); 1975; 17(3):160-7. PubMed ID: 1102394 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study]. Testart J; Guidicelli H; Glanddier G; Mosnier M Ann Cardiol Angeiol (Paris); 1994 Nov; 43(9):542-7. PubMed ID: 7864561 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic use of naftidrofuryl (Praxilene)--peripheral vascular disease. Forrest H Scott Med J; 1978 Jan; 23(1):45-6. PubMed ID: 635540 [No Abstract] [Full Text] [Related]
13. The therapeutic uses of naftidrofuryl (Praxilene)--cerebrovascular disease. Judge TG Scott Med J; 1978 Jan; 23(1):43-4. PubMed ID: 635539 [No Abstract] [Full Text] [Related]
14. Effect of intravenous naftidrofuryl on transcutaneous oxygen pressure in severe peripheral vascular disease. Taggart I; Wishart GC; Cuschieri RJ; MacBain GC Angiology; 1989 Oct; 40(10):895-8. PubMed ID: 2802260 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a vasoactive substance, naftidrofuryl, during the rehabilitation phase after an ischaemic insult. Ducarne H Curr Med Res Opin; 1986; 10(1):58-71. PubMed ID: 3698655 [TBL] [Abstract][Full Text] [Related]
16. Intravenous naftidrofuryl for critical limb ischaemia. Smith FB; Bradbury A; Fowkes G Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD002070. PubMed ID: 22786478 [TBL] [Abstract][Full Text] [Related]
17. The impairment index as a symptom-independent parameter of drug efficacy in geriatric psychopharmacology. Branconnier RJ; Cole JO J Gerontol; 1978 Mar; 33(2):217-23. PubMed ID: 342594 [TBL] [Abstract][Full Text] [Related]